Medical Oncologist
CION Cancer Clinics
Chemotherapy and immunotherapy for biliary tract cancer | CION Cancer Clinics
For advanced bile duct cancer, the usual first treatment is gemcitabine and cisplatin chemotherapy, often combined with an immunotherapy drug. After surgery, capecitabine tablets may be offered. This page explains each option, what happens before treatment starts, who these medicines do not suit, and why the tumour's DNA should be tested. It covers cancer that starts in the bile ducts, not cancer that spread to the liver. At CION Cancer Clinics in Hyderabad, our oncologists explain liver cancer in plain words and plan care around you and your family.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What medicines are used for bile duct cancer?
- Which treatments might my oncologist suggest?
- What happens before the first treatment, and after it starts?
- What do the words on my plan mean?
- Who should not have chemotherapy or immunotherapy for bile duct cancer?
- What this page cannot tell you
- Common questions about medicines for biliary cancer
The short answer
What medicines are used for bile duct cancer?
For most people with bile duct cancer that cannot be removed, or that has spread, the usual first treatment is two chemotherapy drugs, gemcitabine and cisplatin, given together with an immunotherapy drug such as durvalumab or pembrolizumab. After an operation, a chemotherapy tablet called capecitabine is often offered to lower the chance of the cancer coming back.
Which cancers this page is about
Biliary cancer means cancer that starts in the bile ducts, the thin tubes that carry bile from the liver to the gut. It includes cholangiocarcinoma inside the liver and in the ducts just outside it. If your report says the cancer started in the bowel, breast or pancreas and has spread to the liver, this page is not about you. Gallbladder cancer shares many of the same medicines but has its own gallbladder cancer section.
What these medicines can and cannot do
When surgery is not possible, the aim of systemic treatment is control: to shrink the cancer or stop it growing, ease symptoms and give the person more good time. It is rarely expected to make the cancer disappear for good. Your oncologist should tell you plainly which aim applies to you before you start.
Systemic means the medicine travels through the whole body in the blood, so it reaches cancer wherever it is.The main options
Which treatments might my oncologist suggest?
The choice depends on whether the cancer was removed, how well your liver is working, how fit you are, and what the tumour's DNA shows.
Chemotherapy with immunotherapy
Gemcitabine and cisplatin, given in a drip, combined with durvalumab or pembrolizumab. This is now the usual first treatment for advanced biliary cancer in people fit enough to have it. Both immunotherapy drugs are available in India, though cost and insurance cover vary widely.
Read more
Chemotherapy on its own
Gemcitabine and cisplatin without immunotherapy, or a gentler single drug for someone who is frailer or whose kidneys cannot take cisplatin. This remains a sound choice when immunotherapy is not suitable or not affordable.
Tablets after surgery
Capecitabine taken by mouth after the cancer has been removed. It aims to clear cancer cells too small to see on a scan. It is not given to everyone, and your surgeon and oncologist decide together.
Targeted medicines
For tumours with a specific DNA change, such as an FGFR2 fusion or an IDH1 mutation, a targeted drug may be an option, usually after first treatment stops working. Some are not easily available in India and may need import or a clinical trial.
Read more
Not sure whether this applies to you?
Ask an oncologistBefore and during
What happens before the first treatment, and after it starts?
The jaundice is dealt with first
Many people with bile duct cancer are yellow because the duct is blocked. Most chemotherapy is not safe while bilirubin is very high, so a stent or drain usually comes first. Read why a stent comes before treatment.
Tissue is confirmed and tested
A biopsy confirms the diagnosis. The same tissue should be sent for molecular profiling, a DNA test of the tumour, because some bile duct cancers have changes that open a targeted option. It does not promise one. Read why every biliary cancer should be tested.
The tumour board agrees a plan
At CION, the case is discussed by medical, surgical and radiation oncologists together. They weigh the scans, blood tests and your own wishes before a plan is offered to you and your family.
Treatment starts, with regular checks
Chemotherapy and immunotherapy are given at a CION centre. Blood tests check your liver, kidneys and blood counts before each visit, and scans at intervals show whether the cancer is responding.
On your treatment plan
What do the words on my plan mean?
- First-line treatment
- The first medicine plan used for advanced cancer. If it stops working, the next plan is called second-line.
- Adjuvant treatment
- Medicine given after surgery to lower the chance of the cancer coming back. Capecitabine is the usual one for bile duct cancer.
- Immune checkpoint inhibitor
- The group of immunotherapy drugs that includes durvalumab and pembrolizumab. They release a brake that cancer puts on the immune system.
- Molecular profiling
- A DNA test on the tumour tissue that looks for changes such as FGFR2, IDH1, HER2 or MSI, which can point to a targeted medicine.
- Response
- What the scans show after treatment. Stable disease means the cancer has not grown, which is a good result in advanced cancer.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Did you know
Immunotherapy side effects can appear long after a dose, and can affect the liver, bowel, skin or hormone glands. Tell your team about any new diarrhoea, rash or extreme tiredness, even after treatment has finished.
Who this does not suit
Who should not have chemotherapy or immunotherapy for bile duct cancer?
These treatments are not right for everyone, and choosing not to have them is a valid decision. Your oncologist will be cautious, or may advise against them, in several situations.
When the body cannot take it
Someone who spends most of the day in bed, or whose liver or kidneys are failing, is often harmed more than helped. If the jaundice cannot be relieved by a stent or drain, most of these drugs cannot be given safely. Cisplatin is usually avoided in people with weak kidneys or hearing problems.
When immunotherapy carries extra risk
People with an active autoimmune disease, such as severe rheumatoid arthritis or inflammatory bowel disease, or who have had an organ transplant, may not be offered immunotherapy. Active infection in the bile ducts must be treated first.
When the goal is comfort
For some people, good symptom control, pain relief and nutrition support matter more than another drug. Comfort-focused care is not giving up. It can be given alongside treatment or instead of it. Read about treatment when bile duct cancer cannot be removed.
Being straight with you
What this page cannot tell you
It cannot tell you which treatment is right for you, or how you will respond. That depends on where the cancer started, how far it has spread, your liver and kidney blood tests, your fitness and the tumour's DNA result. Only a team that has seen your scans and reports can weigh those together.
It cannot predict how long treatment will work
Averages from trials describe large groups, not one person. Some people do much better than the average and some less well. Ask your oncologist what they expect for you, and what the next step would be if the first plan stops working.
It cannot give you doses or costs
Doses are worked out for each person by their oncologist. Costs depend on the drugs chosen, whether immunotherapy is added and your insurance or scheme. Ask for a written, itemised estimate before you start.
If you already have a plan from another hospital and want it reviewed, CION offers second opinions on biliary cancer treatment.Questions we are asked
Common questions about medicines for biliary cancer
Is immunotherapy always added to chemotherapy now?
Not always. It is the usual first choice for advanced biliary cancer in people who are fit enough and can access it. If cost, insurance, an autoimmune condition or other health problems make it unsuitable, gemcitabine and cisplatin alone is still a reasonable treatment. Your oncologist should explain why one is chosen.
Will I lose my hair?
Gemcitabine and cisplatin usually cause hair thinning rather than complete hair loss, though it differs between people. Tiredness, nausea, a low blood count and infection risk are more common concerns. Your team will tell you which side effects to report the same day.
Can treatment start while I am still jaundiced?
Usually not. A high bilirubin means the liver cannot clear the drugs properly, which makes side effects more dangerous. A stent or external drain normally comes first, and treatment begins once the bilirubin has fallen enough. Your oncologist will decide when it is safe.
What if the stent blocks during treatment?
Fever with shivering, new yellowing or dark urine can mean the stent has blocked and the bile is infected. Go to hospital today and say you have a biliary stent and are on chemotherapy. Read about blocked stents and fever.
Why does the DNA test take time?
Molecular profiling is done in a specialist laboratory and the result can take a while. Many oncologists start first-line treatment without waiting for it, because the first choice rarely changes. The result matters most when deciding what to use next.
Is capecitabine after surgery really needed?
It is commonly offered because it lowers the chance of the cancer coming back for many people. It is not compulsory. Your oncologist will weigh how you recovered from the operation, what the pathology report showed and your own wishes before recommending it.
Does insurance or Aarogyasri cover these drugs?
Chemotherapy is usually covered by health insurance and by government schemes such as Aarogyasri and Ayushman Bharat, within their rules. Cover for immunotherapy varies a lot. The details change, so check with your insurer or scheme desk before starting. CION helps with the paperwork.
Can I have treatment closer to home after it starts?
Many families travel to Hyderabad from districts for the first visits. Once the plan is settled, ask whether some treatment visits or blood tests can happen nearer home. Call the CION helpline to find the centre most convenient for you.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Cholangiocarcinoma Chemotherapy
- American Cancer Society — Bile Duct Cancer Immunotherapy
- American Cancer Society — Bile Duct Cancer Targeted Therapy
- National Cancer Institute — Bile Duct Cancer Treatment
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Why every biliary cancer should be molecularly testedThe DNA test that can open a targeted optionTreatment when bile duct cancer cannot be removedHow medicines fit with stents and comfort careRadiation for bile duct cancerWhere radiation fits alongside these medicinesChemotherapy for gallbladder and bile duct cancerSide effects and day-to-day chemotherapy detail
Talk to us
Want your biliary cancer treatment plan reviewed?
Send us the scans, biopsy and blood reports, and a CION medical oncologist will explain the options in plain language. One helpline serves every CION centre.